跳转至内容
Merck
CN

D030

R(−)-2,10,11-Trihydroxy-N-propyl-noraporphine hydrobromide hydrate

solid

别名:

R(−)-2-OH-NPA HBr, R(−)-TNPA HBr

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C19H21NO3 · HBr · xH2O
化学文摘社编号:
分子量:
392.29 (anhydrous basis)
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


form

solid

optical activity

[α]22/D −64°, c = 7 mg/mL in methanol(lit.)

color

light brown

solubility

alcohol: soluble (Solutions should be freshly prepared.), aqueous acid: moderately soluble (Solutions should be freshly prepared), aqueous base: insoluble

storage temp.

2-8°C

SMILES string

Br.[H][C@]12Cc3ccc(O)c(O)c3-c4cc(O)cc(CCN1CCC)c24

Gene Information

human ... DRD2(1813)

Biochem/physiol Actions

Potent, selective D2 dopamine receptor agonist.


存储类别

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



E Chu et al.
Experimental eye research, 69(6), 611-616 (2000-01-06)
The purpose of this study was to correlate potential mechanisms with site(s) of action for TNPA-induced ocular hypotension. In response to R(-)-2, 10, 11-trihydroxy-N-propyl-noraporphine hydrobromide (TNPA, 75 microg), a D2 dopamine receptor agonist, the intraocular pressure decreased by 4.5 and
Y G Gao et al.
Journal of medicinal chemistry, 33(6), 1800-1805 (1990-06-01)
Syntheses of (R)-(-)-2-methoxyapomorphine (R-8), its antipode S-8, and its (R)-(-)-N-n-propyl R-9 derivatives are described. The dopaminergic receptor affinities of these compounds and their 2-unsubstituted counterparts (R)-(-)-apomorphine (R(-)-APO, R-1), (S)-(+)-apomorphine (S(+)-APO, S-1), and (R)-(-)-N-n-propylnorapomorphine (R(-)-NPA, R-2), as well as those of
E A Jackson et al.
European journal of pharmacology, 87(1), 15-23 (1983-01-28)
The behavioral actions of some novel aporphines have been examined in rats with selective unilateral 6-hydroxydopamine (6OHDA)-induced destruction of nigrostriatal dopaminergic neurons, and in rats with bilateral 6OHDA-induced destruction of mesolimbic dopaminergic neurons. Dopaminomimetics such as apomorphine (APO) in these